Wayne W. Hancock
8Patents
3h-index
22Co-inventors
53Inventor score
Filing activity: Mar 15, 2001 → Jul 28, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9249087B2 | HDAC inhibitors and therapeutic methods using the same | Emerging Cross-Sectional Technologies | 44 | Active |
| US6627637B2 | Substituted beta carbolines | Emerging Cross-Sectional Technologies | 20 | Expired |
| US6534277B1 | Method for identifying a compound to be tested for an ability to reduce immune rejection by determining Stat4 and Stat6 proteins | Chemistry; Metallurgy | 18 | Expired |
| US9717717B1 | Methods of treating cancer through the inhibition of USP7 and immune system modulation | Human Necessities | 2 | Active |
| US7348336B2 | Substituted β-carbolines | Emerging Cross-Sectional Technologies | 2 | Expired |
| USRE47009E1 | HDAC inhibitors and therapeutic methods using the same | General | 2 | Active |
| US7026331B2 | Substituted beta-carbolines | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8497285B2 | Therapy of autoimmune colitis using a TIP60 inhibitor | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.